Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 23, Issue 2, 1999, Pages 195-197

  Van Der Griend, R ^a   Verdonck, L F ^a   Petersen, E J ^a   Veenhuizen, P ^a   Bloem, A C ^a   Lokhorst, H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

BMT; Donor leukocytes; GVHD; Multiple myeloma

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CANCER RECURRENCE; CASE REPORT; CELL INFILTRATION; DONOR; HUMAN; LEUKOCYTE TRANSFUSION; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; PLEURA TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; T LYMPHOCYTE;

EID: 0032911309     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701546     Document Type: Article

References (12)

1. Collins RH Jr, Shpilberg O, Drobyski WR et al. Donor leucocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.
2. Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195-2204.
3. Tricot G, Vesole DH, Jagannath S et al. Graft-versus-myeloma effect: proof of principle. Blood 1996; 87: 1196-1198.
4. Verdonck LF, Lokhorst HM, Dekker AW et al. Graft-versus-myeloma effect in two cases. Lancet 1996; 347: 800-801.
5. Bertz H, Burger JA, Kunzmann R et al. Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect. Leukemia 1997; 11: 281-283.
6. Lokhorst HM, Schattenberg A, Cornelissen JJ et al. Donor leucocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood 1997; 90: 4206-4211.
7. Bakkus MH, Jorge-Morireau M, Werff ten Bosch van der JE et al. Detection of minimal residual disease in multiple myeloma and acute leukemia. Med Oncol 1996; 13: 121-131.
8. Cremer FW, Kiel K, Wallmeier M et al. A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma. Ann Oncol 1997; 8: 633-636.
9. Corradini P, Voena C, Tarella C et al. Molecular and clinical remissions in multiple myeloma: the role of auto/allografting of hematopoietic cells. Bone Marrow Transplant 1998; 21: S206 (Abstr. 721).
10. + donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 1998; 91: 3671-3681.
11. Naparstek E, Or R, Nagler A et al. T cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse. Br J Haematol 1995; 89: 506-515.
12. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756-763.